Professional Documents
Culture Documents
doi: 10.1093/jrr/rrt035
where Rres is expressed in cm and calculated using a prac- MATERIALS AND METHODS
tical range at the 50% dose level Rres(z) = R50 – z, where z
is the depth in water. This expression is based on a 1D ana- Extension of the model to 3D
lysis of dose and sw,air distributions, which is enough to In order to apply expression (1) to calculate stopping power
model the variations in sw,air for homogeneous dose distri- ratios at an arbitrary position of a treatment field, a value of
butions, like the ones mostly used for calibration and Rres, and consequently a value of R50, have to be deter-
quality assurance (QA) purposes. However, this 1D de- mined for every voxel. The process is depicted in Fig. 2.
scription might be insufficient in some cases. An example For each voxel (small box in the figure), its transversal
© The Author 2013. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic
Radiology and Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For
commercial re-use, please contact journals.permissions@oup.com.
i146 D. Sánchez-Parcerisa et al.
Fig. 5. Histograms showing the deviation between the FLUKA-calculated sw,air, the sw,air calculated with the proposed
algorithm and the fixed value of 1.13, for the homogeneous cube (left) and for the head-and-neck field (right). The insets
depict the division of the field into entrance channel (EC), target (T), distal (D) and lateral (L) areas, labeled on
horizontal sections of the respective dose distributions.
the variations of sw,air within the treatment field, as shown 3. Sánchez-Parcerisa D, Gemmel A, Jäkel O et al. Influence of
in Fig. 5 by the clear reduction in the separation between the delta ray production threshold on water-to-air stopping
the different areas of the field. power ratio calculations for carbon ion beam radiotherapy.
When performing treatment plan verification with ioniza- Phys Med Biol 2013; 58:145–58.
4. Hartmann GH, Jakel O, Heeg P et al. Determination of water
tion chambers, a chamber-specific correction accounting for
absorbed dose in a carbon ion beam using thimble ionization
the dependence of sw,air on the effective point of measure-
chambers. Phys Med Biol 1999;44:1193–206.
ment could be implemented in the TPS and would result in 5. Battistoni G, Muraro S, Sala PR et al. The FLUKA code: de-
an improvement of 0.2–0.3% of the overall accuracy of the scription and benchmarking. AIP Conference Proceeding
plan verification module. 896. In: Albrow M., Raja R. (eds). Proceedings of the
Hadronic Shower Simulation Workshop, 2006, 31–49.
6. Ferrari A, Sala PR, Fasso A et al. FLUKA: a multi-particle
FUNDING transport code. CERN-2005-010; INFN/TC_05/11;
SLAC-R-773, Geneva, 2005.
This work was supported by the European Community’s 7. Sigmund P, Schinner A, Paul H. Errata and Addenda
Seventh Framework Program 2007–2013 [Grant number for ICRU Report 73. Stopping of ions heavier than helium.
215840-2, ‘PARTNER’]. J ICRU 2009;5:2.
8. Sánchez-Parcerisa D, Gemmel A, Jäkel O et al. Experimental
study of the water-to-air stopping power ratio of monoener-
REFERENCES getic carbon ion beams for particle therapy. Phys Med Biol
2012;57:3629–41.
1. Karger C, Jäkel O, Palmans H et al. Dosimetry for ion beam 9. Lühr A, Hansen DC, Jäkel O et al. Analytical expressions for
radiotherapy. Phys Med Biol 2010;55:R193–R234. water-to-air stopping-power ratios relevant for accurate dos-
2. IAEA. Absorbed dose determination in external beam radio- imetry in particle therapy. Phys Med Biol 2011;56:2515–33.
therapy. An international code of practice for dosimetry 10. Paul H, Geithner O, Jäkel O. The ratio of stopping powers of
based on standards of absorbed dose to water. Technical water and air for dosimetry applications in tumor therapy.
Report Series No. 398, Vienna, 2000. Nucl Instrum Meth Phys Res B 2007;256:561–4.